JP Stock MarketDetailed Quotes

4886 ASKA Pharmaceutical Holdings

Watchlist
  • 2130
  • -46-2.11%
20min DelayMarket Closed Nov 1 15:00 JST
65.10BMarket Cap7.99P/E (Static)

ASKA Pharmaceutical Holdings Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ASKA Pharmaceutical Holdings Q2 2025 Estimates Date

Currency：JPYNov 5, 2024

Estimate YoY
Revenue
16.03B
+2.59%
Analyst Rating
Buy

Jun 26, 2024

ASKA Pharmaceutical Holdings Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 17.540B--
Nov 5, 20242025/Q2-- / 16.030B--
Aug 5, 20242025/Q116.352B / 16.420B--
May 10, 20242024/Q414.019B / 14.176B--
Feb 5, 20242024/Q317.176B / 17.430B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 17.540B--
Nov 5, 20242025/Q2-- / 16.030B--
Aug 5, 20242025/Q116.352B / 16.420B--
May 10, 20242024/Q414.019B / 14.176B--
Feb 5, 20242024/Q317.176B / 17.430B--

Unlock Free Earnings Estimates

ASKA Pharmaceutical Holdings Earnings Reports

  • ASKA Pharmaceutical Holdings: Supplementary information for the fiscal Q1 financial statement for March 2025.

    Aug 5 02:00 ET

  • ASKA Pharmaceutical Holdings: Short message of Q1 financial results for March 2025 (consolidated, Japanese standard).

    Aug 5 02:00 ET

  • ASKA Pharmaceutical Holdings: Extraordinary Report

    Jun 28 01:12 ET

  • ASKA Pharmaceutical Holdings: Confirmation letter

    Jun 25 00:40 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 26, 2024

    Buy

    • Strong Buy

      50.00%

    • Buy

      0.00%

    • Hold

      50.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data